SCHEMBL17301282

SCHEMBL17301282

C=CC(=O)OCCCCOc1ccc(-c2ccc(C(=O)Oc3ccc(OC(=O)c4ccc(-c5ccc(OCCCCOC(=O)C=C)cc5)cc4)c(C)c3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.44
PPARD Q03181 1/20 0.44
PPARA Q07869 1/20 0.44
THRB P10828 1/20 0.41
MAPT P10636 3/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 2/20 0.40
LMNA P02545 2/20 0.40
KCNH2 Q12809 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
HTT P42858 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RARB P10826 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17301285 0.99 PPARG (0.43) PPARGPPARDPPARATHRBMAPT
SCHEMBL23071727 0.99 PPARG (0.43) PPARGPPARDPPARATHRBMAPT
SCHEMBL17301281 0.98 PPARG (0.47) PPARGPPARDPPARATHRBMAPT
SCHEMBL102915 0.97 THRB (0.44) PPARGPPARDPPARATHRBMAPT
SCHEMBL29809767 0.97 THRB (0.44) PPARGPPARDPPARATHRBMAPT
SCHEMBL17515625 0.96 PPARG (0.51) PPARGPPARDPPARATHRBMAPT
SCHEMBL18803342 0.96 NPC1 (0.44) PPARGPPARDPPARATHRBMAPT
SCHEMBL9106264 0.96 HTT (0.44) PPARGPPARDPPARATHRBMAPT
SCHEMBL20883271 0.96 NPC1 (0.44) PPARGPPARDPPARATHRBMAPT
SCHEMBL9106590 0.96 HTT (0.44) PPARGPPARDPPARATHRBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634638-B2 Liquid crystal composition, reflective layer, method for producing reflective layer, and copolymer FUJIFILM CORPORATION (JP) 2023-04-25 US disclosed
US-11332671-B2 Liquid crystal composition, method for producing reflective layer, reflective layer, cured product, and optically anisotropic body FUJIFILM CORPORATION (JP) 2022-05-17 US disclosed
US-11209688-B2 Reflective layer obtained by immobilizing cholesteric liquid crystalline phase FUJIFILM CORPORATION (JP) 2021-12-28 US disclosed
US-20200231874-A1 LIQUID CRYSTAL COMPOSITION, REFLECTIVE LAYER, METHOD FOR PRODUCING REFLECTIVE LAYER, AND COPOLYMER FUJIFILM CORPORATION (JP) 2020-07-23 US disclosed
US-20200102500-A1 LIQUID CRYSTAL COMPOSITION, METHOD FOR PRODUCING REFLECTIVE LAYER, REFLECTIVE LAYER, CURED PRODUCT, AND OPTICALLY ANISOTROPIC BODY FUJIFILM CORPORATION (JP) 2020-04-02 US disclosed
US-20190033634-A1 METHOD FOR PRODUCING REFLECTIVE LAYER AND REFLECTIVE LAYER FUJIFILM CORPORATION (JP) 2019-01-31 US disclosed
US-20150344782-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL AND METHOD FOR MANUFACTURING THE SAME, AND FILM FUJIFILM CORPORATION (JP) 2015-12-03 US disclosed
US-20150344782-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL AND METHOD FOR MANUFACTURING THE SAME, AND FILM FUJIFILM CORPORATION (JP) 2015-12-03 US disclosed
US-9005906-B2 Tetrahydropyran nucleic acid analogs ISIS PHARMACEUTICALS, INC. (US) 2015-04-14 US disclosed